Extracellular vesicles in the breast cancer brain metastasis: physiological functions and clinical applications

Front Hum Neurosci. 2023 Dec 4:17:1278501. doi: 10.3389/fnhum.2023.1278501. eCollection 2023.

Abstract

Breast cancer, which exhibits an increasing incidence and high mortality rate among cancers, is predominantly attributed to metastatic malignancies. Brain metastasis, in particular, significantly contributes to the elevated mortality in breast cancer patients. Extracellular vesicles (EVs) are small lipid bilayer vesicles secreted by various cells that contain biomolecules such as nucleic acids and proteins. They deliver these bioactive molecules to recipient cells, thereby regulating signal transduction and protein expression levels. The relationship between breast cancer metastasis and EVs has been extensively investigated. In this review, we focus on the molecular mechanisms by which EVs promote brain metastasis in breast cancer. Additionally, we discuss the potential of EV-associated molecules as therapeutic targets and their relevance as early diagnostic markers for breast cancer brain metastasis.

Keywords: biomarker; blood-brain barrier (BBB); breast cancer brain metastases; exosomes; extracellular vesicles (EVs).

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Project for Cancer Research and Therapeutic Evolution (P-PROMOTE) from the Japan Agency for Medical Research and Development (AMED) (No. 23ama221405h0002) and CREST from the Japan Science and Technology Agency (No. JPMJCR19H1).